iRhythm Technologies Announces Results of GUARD-AF Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Caribou Biosciences to halt CAR-T programs, explore sale
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
Oppenheimer Reiterates Outperform Rating on iRhythm Technologies (IRTC)
September 3, 2024 6:08 AM EDTOppenheimer analyst Suraj Kalia reiterated an Outperform rating and $145.00 price target on iRhythm Technologies (NASDAQ: IRTC).
The analyst comments "On Sunday (9/2), GUARD-AF trial results were presented at ESC Congress 2024, and simultaneously published online (link1/link2). The trial, which was halted prematurely due to the... More



